Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22087

1.

In Silico Structural Homology Modelling and Docking for Assessment of Pandemic Potential of a Novel H7N9 Influenza Virus and Its Ability to Be Neutralized by Existing Anti-Hemagglutinin Antibodies.

Rajapaksha H, Petrovsky N.

PLoS One. 2014 Jul 21;9(7):e102618. doi: 10.1371/journal.pone.0102618. eCollection 2014.

PMID:
25047593
[PubMed - as supplied by publisher]
2.

Comparison of the safety and immunogenicity of an MF59<sup>®</sup>-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects.

Frey SE, Reyes MR, Reynales H, Bermal NN, Nicolay U, Narasimhan V, Forleo-Neto E, Arora AK.

Vaccine. 2014 Jul 18. pii: S0264-410X(14)00939-6. doi: 10.1016/j.vaccine.2014.07.013. [Epub ahead of print]

PMID:
25045825
[PubMed - as supplied by publisher]
3.

Seasonal influenza vaccination trends from 2007-2011 in privately insured children and adults in the United States.

Antonova E, Ambrose CS, Kern D, Block SL, Caspard H, Tunceli O.

Vaccine. 2014 Jul 18. pii: S0264-410X(14)00935-9. doi: 10.1016/j.vaccine.2014.07.009. [Epub ahead of print]

PMID:
25045823
[PubMed - as supplied by publisher]
4.

Influenza vaccine as prevention for cardiovascular diseases: Possible molecular mechanism.

Veljkovic V, Glisic S, Veljkovic N, Bojic T, Dietrich U, Perovic VR, Colombatti A.

Vaccine. 2014 Jul 18. pii: S0264-410X(14)00933-5. doi: 10.1016/j.vaccine.2014.07.007. [Epub ahead of print]

PMID:
25045818
[PubMed - as supplied by publisher]
5.

Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine: Results from a double-blinded, randomized Phase I clinical trial in healthy Asian volunteers.

Low JG, Lee LS, Ooi EE, Ethirajulu K, Yeo P, Matter A, Connolly JE, Skibinski DA, Saudan P, Bachmann M, Hanson BJ, Lu Q, Maurer-Stroh S, Lim S, Novotny-Diermayr V.

Vaccine. 2014 Jul 18. pii: S0264-410X(14)00937-2. doi: 10.1016/j.vaccine.2014.07.011. [Epub ahead of print]

PMID:
25045806
[PubMed - as supplied by publisher]
6.

Humanized antibody neutralizing 2009 pandemic H1N1 virus.

Shembekar N, Mallajosyula VV, Chaudhary P, Upadhyay V, Varadarajan R, Gupta SK.

Biotechnol J. 2014 Jul 7. doi: 10.1002/biot.201400083. [Epub ahead of print]

PMID:
25044602
[PubMed - as supplied by publisher]
7.

T cell mediated immunity to influenza: mechanisms of viral control.

La Gruta NL, Turner SJ.

Trends Immunol. 2014 Jul 16. pii: S1471-4906(14)00109-4. doi: 10.1016/j.it.2014.06.004. [Epub ahead of print] Review.

PMID:
25043801
[PubMed - as supplied by publisher]
8.

Divergent immune responses and disease outcomes in piglets immunized with inactivated and attenuated H3N2 swine influenza vaccines in the presence of maternally-derived antibodies.

Sandbulte MR, Platt R, Roth JA, Henningson JN, Gibson KA, Rajão DS, Loving CL, Vincent AL.

Virology. 2014 Jul 17;464-465C:45-54. doi: 10.1016/j.virol.2014.06.027. [Epub ahead of print]

PMID:
25043588
[PubMed - as supplied by publisher]
9.

An important amino acid in nucleoprotein contributes to influenza A virus replication by interacting with polymerase PB2.

Gui X, Li R, Zhang X, Shen C, Yu H, Guo X, Kang Y, Chen J, Chen H, Chen Y, Xia N.

Virology. 2014 Jul 17;464-465C:11-20. doi: 10.1016/j.virol.2014.06.033. [Epub ahead of print]

PMID:
25043584
[PubMed - as supplied by publisher]
10.

Skin Immunization with Influenza Vaccines.

Skountzou I, Compans RW.

Curr Top Microbiol Immunol. 2014 Jul 20. [Epub ahead of print]

PMID:
25038939
[PubMed - as supplied by publisher]
11.

Inactivated and Adjuvanted Influenza Vaccines.

Del Giudice G, Rappuoli R.

Curr Top Microbiol Immunol. 2014 Jul 20. [Epub ahead of print]

PMID:
25038938
[PubMed - as supplied by publisher]
12.

Molecular Determinants of Influenza Virus Pathogenesis in Mice.

Kamal RP, Katz JM, York IA.

Curr Top Microbiol Immunol. 2014 Jul 20. [Epub ahead of print]

PMID:
25038937
[PubMed - as supplied by publisher]
13.

Structural Characterization of Viral Epitopes Recognized by Broadly Cross-Reactive Antibodies.

Lee PS, Wilson IA.

Curr Top Microbiol Immunol. 2014 Jul 19. [Epub ahead of print]

PMID:
25037260
[PubMed - as supplied by publisher]
14.

Dissecting the Immune-Response to MF59®-Adjuvanted and Non-Adjuvanted Seasonal Influenza Vaccines in Children Less Than Three Years of Age.

Zedda L, Forleo-Neto E, Vertruyen A, Raes M, Marchant A, Jansen W, Clouting H, Arora A, Beatty ME, Galli G, Del Giudice G, Castellino F.

Pediatr Infect Dis J. 2014 Jul 16. [Epub ahead of print]

PMID:
25037034
[PubMed - as supplied by publisher]
15.

Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases.

Altenburg AF, Kreijtz JH, de Vries RD, Song F, Fux R, Rimmelzwaan GF, Sutter G, Volz A.

Viruses. 2014 Jul 17;6(7):2735-61. doi: 10.3390/v6072735.

PMID:
25036462
[PubMed - in process]
Free Article
16.

Epitope-specific regulation of memory programming by differential duration of antigen presentation to influenza-specific CD8(+) T cells.

Ballesteros-Tato A, León B, Lee BO, Lund FE, Randall TD.

Immunity. 2014 Jul 17;41(1):127-40. doi: 10.1016/j.immuni.2014.06.007.

PMID:
25035957
[PubMed - in process]
17.

Influenza vaccination in patients with diabetes: disparities in prevalence between African Americans and Whites.

Athamneh LN, Sansgiry SS.

Pharm Pract (Granada). 2014 Apr;12(2):410. Epub 2014 Mar 15.

PMID:
25035719
[PubMed]
Free PMC Article
18.

Transcriptional activity comparison of different sites in recombinant Marek's disease virus for the expression of the H9N2 avian influenza virus hemagglutinin gene.

Zhang F, Chen W, Ma C, Zhang Z, Zhao P, Du Y, Zhang Y, Duan L, Fang J, Li S, Su H, Cui H, Cui Z.

J Virol Methods. 2014 Jul 14. pii: S0166-0934(14)00267-5. doi: 10.1016/j.jviromet.2014.07.011. [Epub ahead of print]

PMID:
25034124
[PubMed - as supplied by publisher]
19.

A micro-sterile inflammation array as an adjuvant for influenza vaccines.

Wang J, Shah D, Chen X, Anderson RR, Wu MX.

Nat Commun. 2014 Jul 18;5:4447. doi: 10.1038/ncomms5447.

PMID:
25033973
[PubMed - in process]
20.

Influenza Neuraminidase as a Vaccine Antigen.

Eichelberger MC, Wan H.

Curr Top Microbiol Immunol. 2014 Jul 18. [Epub ahead of print]

PMID:
25033754
[PubMed - as supplied by publisher]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk